Hot Topics Archive
CME credits for these Hot Topics have now expired but you may still view them for information.
- The hygiene hypothesis: An "old friend" driving the rise in IBD incidence?
Presented By: L. Campbell Levy, MD - Update on concomitant immunomodulators and biologics: Reconciling the SONIC and COMMIT trials
Presented By: Stephen B. Hanauer, MD - Managing patients who have failed their first biologic treatment
Presented By: Stephen B. Hanauer, MD - Psychological outcomes and quality-of-life in Crohn’s disease: From clinical research to
clinical practice
Presented By: Charles N. Bernstein, MD - Pouchitis: When is it Crohn's disease and what to do about it?
Presented By: Bo Shen, MD - Transitioning adolescents with IBD to adult healthcare
Presented By: Elizabeth J. Hait, MD, MPH - Vaccinations for patients with Crohn's disease: Who needs them and who can’t get them?
Presented By: Corey A. Siegel, MD & John F. Modlin, MD - The use of complementary medicine in inflammatory bowel disease
Presented By: Shane M. Devlin, MD, FRCPC - Genetic testing in Crohn's disease
Presented By: Dermot P.B. McGovern, MB BS, PhD, MRCP - The role of capsule endoscopy in the diagnosis and differentiation of IBD
Presented By: Jonathan A. Leighton, MD - Serologic markers in inflammatory bowel disease: Uses, limitations, and future directions
Presented By: Seamus J. Murphy, MD and Maria T. Abreu, MD - Probiotics, prebiotics, and antibiotics in preventing and treating inflammatory bowel disease
Presented By: Balfor Sartor, MD - Natural history of Crohn's disease: Influence of treatment
Presented By: Severine Vermeire, MD - Practical tips for switching anti-TNF-α therapy
Presented By: Bruce E. Sands, MD, MS - Pregnancy in Crohn's disease
Presented by: Uma Mahadevan-Velayos, MD - What should we tell our patients about the risks of inflammatory bowel disease therapies?
Presented by: Corey A. Siegel, MD - Early intervention: Evidence for the use of biologics as first-line treatment for Crohn's disease
Presented by: Brian G. Feagan, MD - Use of concomitant immunomodulators and anti-TNF-α therapies in patients with Crohn’s disease
Presented by: Marla C. Dubinsky, MD - Safety profile of anti-TNF-α therapies
Presented by: Remo Panaccione, MD, FRCPSC - Defining failure of anti-TNF-α therapy
Presented by: Bret A. Lashner, MD
